April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Role of PKA on Photoreceptor Degeneration in the rd1 Mouse Model
Author Affiliations & Notes
  • S. Kustermann
    Institute for Ophthalmic Research, Centre for Ophthalmology, Tuebingen, Germany
  • T. van Veen
    Institute for Ophthalmic Research, Centre for Ophthalmology, Tuebingen, Germany
    Dept. Ophthalmology, Clinical Sciences, University of Lund, Lund, Sweden
  • W. Raffelsberger
    IGBMC, Strasbourg, France
  • P. Ekström
    Dept. Ophthalmology, Clinical Sciences, University of Lund, Lund, Sweden
  • F. Paquet-Durand
    Institute for Ophthalmic Research, Centre for Ophthalmology, Tuebingen, Germany
  • Footnotes
    Commercial Relationships  S. Kustermann, None; T. van Veen, None; W. Raffelsberger, None; P. Ekström, None; F. Paquet-Durand, None.
  • Footnotes
    Support  Foundation Fighting Blindness; DFG (PA 1751/1-1); Kerstan Foundation; RETNET: MRTN-CT-2003-504003
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4470. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Kustermann, T. van Veen, W. Raffelsberger, P. Ekström, F. Paquet-Durand; Role of PKA on Photoreceptor Degeneration in the rd1 Mouse Model. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4470.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : PKA, a cAMP dependent protein kinase, is important in activating the transcription factor CREB (cAMP response element-binding protein) which is crucially involved in neuronal survival. Previously it has been demonstrated that in the rd1 mouse, a model for retinal degeneration, retinal CREB is significantly downregulated (Azadi et al., 2006). Furthermore, PKA bears the potential to stabilize ICER (inducible cAMP early repressor) which is the endogenous inhibitor of CREB. To investigate this bivalent role of PKA and the impact of PKA on photoreceptor cell survival we specifically activated or inhibited PKA activity in retinal explants of the rd1 mouse.

Methods: : Retinas from rd1 mice at postnatal day 5 were cultured in an organotypic culture system for 6 days in total. After 2 days in vitro (DIV) retinal explants were treated for 4 days by adding PKA inhibitor (RP-8-CPT-cAMPS) or activator (SP-8-CPT-cAMPS) to the culture medium. Cell death after treatment was assessed using TUNEL assay and cell death rate was calculated as TUNEL positive cells / µm² of outer nuclear layer (ONL).

Results: : After treating retinal explants of rd1 mice for 4 days with a PKA inhibitor we could not observe any significant differences in the number of dying cells within the ONL (3.7 control vs. 3.2 treated) as revealed by TUNEL staining. In an additional set of experiments we could demonstrate that 4 days treatment of retinal explants with a PKA activator showed no significant changes in the amount of dying cells (3.4 control vs. 3.1 treated).

Conclusions: : Increased PKA activity as well as PKA inhibition has no apparent impact on photoreceptor cell death in the rd1 mouse model, at least under the short term treatment conditions used here. Further investigations will be needed to demonstrate any potential role of PKA in fine tuning of CREB dependent transcription or on other parameters of the retinal degeneration in the rd1 mouse.

Keywords: retinal degenerations: cell biology • transcription factors • protective mechanisms 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×